{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:12:46Z","timestamp":1648566766603},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T00:00:00Z","timestamp":1336003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Streptococcus pneumoniae<\/jats:italic> is a leading cause of invasive infection in young children causing morbidity and mortality. Active surveillance systems of invasive pneumococcal disease (IPD) are recommended worldwide. The aim of this study was to estimate the current incidence of IPD and to describe the serotype distribution and the antimocrobial susceptibility of <jats:italic>S. pneumoniae<\/jats:italic> isolates in children aged less than 5\u2009years residing in North-West Lombardy, Italy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A twelve-month prospective active surveillance system recruited all children aged less than 5\u2009years admitted for suspicion of IPD at emergency room of ten hospitals located in the monitored area. Blood samples were taken in all participants for confirmation of IPD based on isolation of <jats:italic>S. pneumoniae<\/jats:italic> from blood. Pneumococcal meningitis and sepsis were additionally confirmed by cerebrospinal fluid analysis. Serotyping and antimicrobial susceptibility testing were performed on isolates from blood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 15 confirmed cases of IPD were detected among 135 recruited children, including pneumonia (n\u2009=\u20098), bacteremia (n\u2009=\u20094), sepsis (n\u2009=\u20092) and meningitis (n\u2009=\u20091). The annual IPD incidence rate was 50.0\/100,000 (95%CI, 30.5-82.5\/100,000). Incidence was 58.3\/100,000 (28.8-120.1\/100,000) among children aged less than 2\u2009years and 44.4\/100,000 (22.9-87.5\/100,000) among children aged 2\u20134\u2009years. Thirteen isolates were typified. The most common serotype was 19A (23.1%) that together with serotypes 1, 7F and 19F accounted for 69.2% of typified isolates. Serotypes 14, 23F, 12B and 15C were also identified. The 7- and 13-valent pneumococcal conjugate vaccines covered respectively 30.8% and 84.6% of typified IPD cases. One isolate (serotype 15C) was penicillin-resistant and caused meningitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The inclusion of the 13-valent pneumococcal conjugate vaccine in immunization programs of young children might be considered to reduce incidence and morbidity of invasive pneumococcal disease in this surveilled population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-12-106","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T10:15:27Z","timestamp":1336040127000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The status of invasive pneumococcal disease among children younger than 5\u2009years of age in north-west Lombardy, Italy"],"prefix":"10.1186","volume":"12","author":[{"given":"Enrica","family":"Riva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Salvini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Laura","family":"Garlaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,3]]},"reference":[{"key":"1915_CR1","first-page":"110","volume":"78","author":"World Health Organization (WHO)","year":"2003","unstructured":"World Health Organization (WHO): Pneumococcal vaccines. Wkly Epidemiol Rec. 2003, 78: 110-119.","journal-title":"Wkly Epidemiol Rec"},{"key":"1915_CR2","first-page":"93","volume":"82","author":"World Health Organization (WHO)","year":"2007","unstructured":"World Health Organization (WHO): Pneumococcal conjugate vaccine for childhood immunization \u2014WHO position paper. Wkly Epidemiol Rec. 2007, 82: 93-104.","journal-title":"Wkly Epidemiol Rec"},{"key":"1915_CR3","unstructured":"Deloria-Knoll M, O\u2019Brien KL, Henkle E, Lee E, Watt JP, McCall N, Mangtani P: Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than five years of age, 1980\u20132005. http:\/\/whqlibdoc.who.int\/hq\/2009\/WHO_IVB_09.02_eng.pdf (accessed October 29, 2011)."},{"key":"1915_CR4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O'Brien","year":"2009","unstructured":"O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Hib and Pneumococcal Global Burden of Disease Study Team: Burden of disease caused by Streptococcus pneumoniae in children younger than 5\u2009years: global estimates. Lancet. 2009, 374: 893-902. 10.1016\/S0140-6736(09)61204-6.","journal-title":"Lancet"},{"key":"1915_CR5","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"CG Whitney","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance of the Emerging Infections Program Network: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003, 348: 1737-1746. 10.1056\/NEJMoa022823.","journal-title":"N Engl J Med"},{"key":"1915_CR6","first-page":"144","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","unstructured":"Centers for Disease Control and Prevention (CDC): Invasive pneumococcal dis ease in children 5 years after conjugate vaccine introduction - eight states, 1998\u20132005. MMWR Morb Mortal Wkly Rep. 2008, 57: 144-148.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1915_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3201\/eid1605.091223","volume":"16","author":"GD Rodenburg","year":"2010","unstructured":"Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM, Hak E, Spanjaard L, Sanders EA, van der Ende A: Effects of pneumococcal conjugate vaccine 2\u2009years after its introduction, the Netherlands. Emerg Infect Dis. 2010, 16: 816-823.","journal-title":"Emerg Infect Dis"},{"key":"1915_CR8","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.vaccine.2010.01.017","volume":"28","author":"ZB Harboe","year":"2010","unstructured":"Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, Howitz M, Krogfelt KA, Lambertsen L, Konradsen HB: Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine. 2010, 28: 2642-2647. 10.1016\/j.vaccine.2010.01.017.","journal-title":"Vaccine"},{"key":"1915_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.vaccine.2009.10.121","volume":"28","author":"M Pulido","year":"2010","unstructured":"Pulido M, Sorvillo F: Declining invasive pneumococcal disease mortality in the United States, 1990\u20132005. Vaccine. 2010, 28: 889-892. 10.1016\/j.vaccine.2009.10.121.","journal-title":"Vaccine"},{"key":"1915_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1086\/521626","volume":"196","author":"LA Hicks","year":"2007","unstructured":"Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG: Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004. J Infect Dis. 2007, 196: 1346-1354. 10.1086\/521626.","journal-title":"J Infect Dis"},{"key":"1915_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3181c15471","volume":"29","author":"KK Hsu","year":"2010","unstructured":"Hsu KK, Shea KM, Stevenson AE, SI Pelton, Massachusetts Department of Public Health: Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001\u20132007. Pediatr Infect Dis J. 2010, 29: 289-293.","journal-title":"Pediatr Infect Dis J"},{"key":"1915_CR12","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1016\/j.vaccine.2009.06.091","volume":"27","author":"YC Hsieh","year":"2009","unstructured":"Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, Chiu NC, Chuang YC, Chen PY, Chang SC, Liu JW, Yen MY, Wang JH, Liu CY, Lin TY: National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine. 2009, 27: 5513-5518. 10.1016\/j.vaccine.2009.06.091.","journal-title":"Vaccine"},{"key":"1915_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3201\/eid1402.070807","volume":"14","author":"EH Choi","year":"2008","unstructured":"Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ: Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis. 2008, 14: 275-281. 10.3201\/eid1402.070807.","journal-title":"Emerg Infect Dis"},{"key":"1915_CR14","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.vaccine.2010.09.100","volume":"29","author":"A Skoczy\u0144ska","year":"2011","unstructured":"Skoczy\u0144ska A, Sadowy E, Bojarska K, Strzelecki J, Kuch A, Go\u0142\u0119biewska A, Wa\u015bko I, Fory\u015b M, van der Linden M, Hryniewicz W, Participants of a laboratory-based surveillance of community acquired invasive bacterial infections (BINet): The current status of invasive pneumococcal disease in Poland. Vaccine. 2011, 29: 2199-2205. 10.1016\/j.vaccine.2010.09.100.","journal-title":"Vaccine"},{"key":"1915_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1542\/peds.2008-1702","volume":"125","author":"SL Kaplan","year":"2010","unstructured":"Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO: Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010, 125: 429-436. 10.1542\/peds.2008-1702.","journal-title":"Pediatrics"},{"key":"1915_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","volume":"5","author":"WP Hausdorff","year":"2005","unstructured":"Hausdorff WP, Feikin DR, Klugman KP: Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005, 5: 83-93.","journal-title":"Lancet Infect Dis"},{"key":"1915_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1586\/erv.09.68","volume":"8","author":"EC Dinleyici","year":"2009","unstructured":"Dinleyici EC, Yargic ZA: Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. Expert Rev Vaccines. 2009, 8: 977-986. 10.1586\/erv.09.68.","journal-title":"Expert Rev Vaccines"},{"key":"1915_CR18","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.vaccine.2004.10.037","volume":"23","author":"F D'Ancona","year":"2005","unstructured":"D'Ancona F, Salmaso S, Barale A, Boccia D, Lopalco PL, Rizzo C, Monaco M, Massari M, Demicheli V, Pantosti A, Italian PNC-Euro working group: Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine. 2005, 23: 2494-2500. 10.1016\/j.vaccine.2004.10.037.","journal-title":"Vaccine"},{"key":"1915_CR19","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1016\/j.vaccine.2006.05.012","volume":"24","author":"L Tarallo","year":"2006","unstructured":"Tarallo L, Tancredi F, Schito G, Marchese A, Bella A, Italian Pneumonet Group (Societ\u00e0 Italiana Pediatria and Associazione Italiana Studio Antimicrobici e Resistenze): Active surveillance of Streptococcus pneumoniae bacteremia in Italian children. Vaccine. 2006, 24: 6938-6943. 10.1016\/j.vaccine.2006.05.012.","journal-title":"Vaccine"},{"key":"1915_CR20","first-page":"619","volume":"21","author":"S Tardivo","year":"2009","unstructured":"Tardivo S, Poli A, Zerman T, D'Elia R, Chiamenti G, Torri E, Bonetti A, Pedevilla E, Pancheri P, Lubrano P, Savastano R, Meneghelli G, Romano G: Invasive pneumococcal infections in infants up to three years of age: results of a longitudinal surveillance in North-East Italy. Ann Ig. 2009, 21: 619-628.","journal-title":"Ann Ig"},{"key":"1915_CR21","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1016\/j.vaccine.2009.01.052","volume":"27","author":"P Durando","year":"2009","unstructured":"Durando P, Crovari P, Ansaldi F, Sticchi L, Sticchi C, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, Azzari C, Icardi G, Collaborative Group for Pneumococcal Vaccination in Liguria: Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine. 2009, 27: 3459-3462. 10.1016\/j.vaccine.2009.01.052.","journal-title":"Vaccine"},{"key":"1915_CR22","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0196-0644(05)80991-6","volume":"22","author":"LJ Baraff","year":"1993","unstructured":"Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Powell KR, Schriger DL: Practice guideline for the management of infants and children 0 to 36\u2009months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. 1993, 22: 1198-2210. 10.1016\/S0196-0644(05)80991-6.","journal-title":"Ann Emerg Med"},{"key":"1915_CR23","first-page":"1","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention: Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997, 46: 1-55.","journal-title":"MMWR Recomm Rep"},{"key":"1915_CR24","volume-title":"International Classification of Diseases, 9th Revision","author":"World Health Organization","year":"1980","unstructured":"World Health Organization: International Classification of Diseases, 9th Revision. 1980, World Health Organization, Geneva, Switzerland"},{"key":"1915_CR25","volume-title":"Manual for the surveillance of vaccine-preventable diseases. Chapter 11: Pneumococcal","author":"Centers for Disease Control and Prevention","year":"2008","unstructured":"Centers for Disease Control and Prevention: Manual for the surveillance of vaccine-preventable diseases. Chapter 11: Pneumococcal. 2008, Centers for Disease Control and Prevention, Atlanta, GA, http:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt11-pneumo.htm (accessed October 29, 2011)., 4","edition":"4"},{"key":"1915_CR26","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement; M100-S19","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement; M100-S19. 2009, Clinical and Laboratory Standards Institute, Wayne"},{"key":"1915_CR27","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","volume":"14","author":"DJ Isaacman","year":"2010","unstructured":"Isaacman DJ, McIntosh ED, Reinert RR: Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010, 14: e197-e209.","journal-title":"Int J Infect Dis"},{"key":"1915_CR28","first-page":"893","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","unstructured":"Centers for Disease Control and Prevention: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998\u20132003. MMWR Morb Mortal Wkly Rep. 2005, 54: 893-897.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1915_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2334-10-90","volume":"10","author":"A Melegaro","year":"2010","unstructured":"Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ: Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis. 2010, 10: 90-10.1186\/1471-2334-10-90.","journal-title":"BMC Infect Dis"},{"key":"1915_CR30","first-page":"pii: 19159","volume":"14","author":"H De Carvalho Gomes","year":"2009","unstructured":"De Carvalho Gomes H, Muscat M, Monnet DL, Giesecke J, Lopalco PL: Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001\u20132007. Euro Surveill. 2009, 14: pii: 19159-","journal-title":"Euro Surveill"},{"key":"1915_CR31","volume-title":"Dati di sorveglianza delle malattie batteriche invasive -aggiornati al 04 aprile 2011 [in Italian]","author":"Istituto Superiore di Sanit\u00e0","year":"2010","unstructured":"Istituto Superiore di Sanit\u00e0: Dati di sorveglianza delle malattie batteriche invasive -aggiornati al 04 aprile 2011 [in Italian]. 2010, Istituto Superiore di Sanit\u00e0, Rome, Italy, http:\/\/www.simi.iss.it\/dati.htm (accessed October 29, 2011)."},{"key":"1915_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MOP.0b013e328341d1f5","volume":"23","author":"CG Grijalva","year":"2011","unstructured":"Grijalva CG, Pelton SI: A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Curr Opin Pediatr. 2011, 23: 98-104. 10.1097\/MOP.0b013e328341d1f5.","journal-title":"Curr Opin Pediatr"},{"key":"1915_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10096-007-0294-4","volume":"26","author":"J Aristegui","year":"2007","unstructured":"Aristegui J, Bernaola E, Pocheville I, Garc\u00eda C, Arranz L, Dur\u00e1n G, P\u00e9rez L, Bastida M, Canduela C, Herranz Aguirre M, Garrote E, Fletcher MA, P\u00e9rez C: Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis. 2007, 26: 303-310. 10.1007\/s10096-007-0294-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1915_CR34","unstructured":"Nuorti JP, Whitney CG: Centers for Disease Control and Prevention: Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010, 59 (1):"},{"key":"1915_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1574-695X.2000.tb01521.x","volume":"29","author":"K Overweg","year":"2000","unstructured":"Overweg K, Sluijter M, Srodzinski M, de Groot R, Hermans PW: Immune-protective antibodies against capsular polysaccharides do not affect natural competence of Streptococcus pneumoniae: implications for current conjugate vaccination strategies?. FEMS Immunol Med Microbiol. 2000, 29: 183-185. 10.1111\/j.1574-695X.2000.tb01521.x.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1915_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.vaccine.2004.07.024","volume":"23","author":"AP Brandao","year":"2004","unstructured":"Brandao AP, de Oliveira TC, de Cunto Brandileone MC, Goncalves JE, Yara TI, Simonsen V: Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil. Vaccine. 2004, 23: 762-768. 10.1016\/j.vaccine.2004.07.024.","journal-title":"Vaccine"},{"key":"1915_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/01.inf.0000207484.52850.38","volume":"25","author":"BE Gonzalez","year":"2006","unstructured":"Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO, U.S. Pediatric Multicenter Pneumococcal Surveillance Group: Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J. 2006, 25: 301-305. 10.1097\/01.inf.0000207484.52850.38.","journal-title":"Pediatr Infect Dis J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-106\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:20:38Z","timestamp":1630524038000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-106","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]},"assertion":[{"value":"18 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"106"}}